Prometheus Laboratories Inc.
5739 Pacific Center Boulevard
73 articles with Prometheus Laboratories Inc.
Prometheus Laboratories Inc. Launches the First Serogenetic Test to Predict Risk of Complications From Crohn's Disease
Prometheus Laboratories Inc. to Present New Data on Proprietary Oncology Diagnostic Platform at American Society of Clinical Oncology Annual Meeting
Prometheus Laboratories Inc. Announces New Method for Real-Time Monitoring of Patients Treated With Biologic Therapy
Prometheus Laboratories Inc. Unveils Novel Approach for Predicting Risk of Disease Progression in Patients with Crohn's Disease
Prometheus Laboratories Inc. and Bayer Schering Pharma to Apply Novel Diagnostic Platform to Oncology Therapeutic Candidates; Prometheus Eligible for Upfront and Milestone Payments up to $160 Million
Prometheus Laboratories Inc. Awarded Patent Related to Genetic Testing for Inflammatory Bowel Disease Patent Includes NOD2 Gene Mutations Associated with Susceptibility to Crohn's Disease
Appeals Court Rules in Favor of Prometheus Laboratories Inc., Upholds the Patentability of Its Claims for Methods of Thiopurine Metabolite Testing
Prometheus Laboratories Inc. Launches MyCeliacID(TM), the First Do it Yourself, Saliva-Based Genetic Test Dedicated to Celiac Disease
Prometheus Laboratories Inc. Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
Prometheus Laboratories Inc. Presents Proprietary Oncology Diagnostic Platform at American Society of Clinical Oncology Annual Meeting
Rosetta Genomics Ltd. Announces Closing of License and Collaboration Agreement with Prometheus Laboratories Inc.
Prometheus Laboratories Inc. Presents New Clinical Insights Into Diagnosis of Crohn's Disease in Children from Analysis of PROMETHEUS(R) IBD Serology 7 Test Results
Prometheus Laboratories Inc. Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing
Prometheus Laboratories Inc. Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting